Accelerating COVID-19 and other Vaccine Trials without Sacrificing Data Quality

This article presents how an eDiary vaccine platform provides a consistent means to capture all forms of study participant data in a regulatory-compliant and time-efficient manner, helping sponsors meet FPI, capture the highest quality data and ultimately, get their vaccines to market sooner.

 

 

 

ERT_Accelerating COVID Vaccine Trials_ICT_May 2020
Share